Assessing the Impact of COVID-19 Patients Long Distance Transfers Between Intensive Care Units
TRANSCOV
TRANSCOV Cohort. An Epidemiological Study Assessing the Impact of Critically Ill COVID-19 Patients Long Distance Transfers Between Intensive Care Units
1 other identifier
observational
3,060
1 country
1
Brief Summary
The TRANSCOV cohort is a multicentre observational retrospective study aiming at assessing the health impact of extra regional transfers of critically ill COVID-19 patients.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Mar 2021
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 1, 2021
CompletedFirst Submitted
Initial submission to the registry
June 16, 2021
CompletedFirst Posted
Study publicly available on registry
June 18, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2022
CompletedJune 22, 2021
June 1, 2021
10 months
June 16, 2021
June 17, 2021
Conditions
Outcome Measures
Primary Outcomes (1)
Survival
Status alive or dead
1 year
Study Arms (2)
Transferred group
The transferred group includes all severe COVID patients admitted in a French ICU ward and then transferred between the 03/13/2020 and 04/10/2020 to another ICU located outside the region of the initial ICU stay.
Control group
The control group includes patients selected out of those whose entire ICU care has taken place in one of the hospitals which transferred patients. Up to 4 control patients will be selected for each transferred patient.
Interventions
Individual or grouped transportation between ICU of severely ill patients using ambulance, plane, helicopter, train or boat, with specialist medical assistance.
Eligibility Criteria
Severely ill COVID-19 patients
You may qualify if:
- COVID-19 patients diagnosed biologically or by imaging
- Admission in ICU between 03/13/2020 and 04/10/2020
You may not qualify if:
- none
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
EHESP
Rennes, 35043, France
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Olivier Grimaud, Ph.D., M.D.
Ecole des Hautes Etudes en Santé Publique
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Head of the deparment Quantitative Methods in Public Health
Study Record Dates
First Submitted
June 16, 2021
First Posted
June 18, 2021
Study Start
March 1, 2021
Primary Completion
December 31, 2021
Study Completion
December 31, 2022
Last Updated
June 22, 2021
Record last verified: 2021-06